Evidence map›Paper›PMID 35287205›Full record

ReviewAnalytical sciences : the international journal of the Japan Society for Analytical Chemistry2022

Recent advances in nephropathy biomarker detections using paper-based analytical devices.

Akhmad Sabarudin, Setyawan P Sakti, Aulanni'am, Hani Susianti, Nur Samsu, Ika O Wulandari, Yudit Oktanella, Dewi Anggraeni

Abstract readReview
PubMed Publisher
In one paragraph

Review in Analytical sciences : the international journal of the Japan Society for Analytical Chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 7 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Akhmad SabarudinDepartment of Chemistry, Faculty of Science, Brawijaya University, Jl Veteran, Malang, 65145, Indonesia. sabarjpn@ub.ac.id.
Setyawan P SaktiDepartment of Physics, Faculty of Science, Brawijaya University, Jl Veteran, Malang, 65145, Indonesia.
Aulanni'amDepartment of Chemistry, Faculty of Science, Brawijaya University, Jl Veteran, Malang, 65145, Indonesia.
Hani SusiantiDepartment of Clinical Pathology, Faculty of Medicine, Brawijaya University, Jl Veteran, Malang, 65145, Indonesia.
Nur SamsuDepartment of Internal Medicine, Faculty of Medicine, Brawijaya University, Jl Veteran, Malang, 65145, Indonesia.
Ika O WulandariDepartment of Chemistry, Faculty of Science, Brawijaya University, Jl Veteran, Malang, 65145, Indonesia.
Yudit OktanellaDepartment of Animal Reproduction, Faculty of Veterinary Medicine, Brawijaya University, Jl Veteran, Malang, 65145, Indonesia.
Dewi AnggraeniDepartment of Physics, Faculty of Science, Brawijaya University, Jl Veteran, Malang, 65145, Indonesia.
University of Brawijaya · ID

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nephropathy or kidney disease involves the deterioration of kidney functions, causing severe diseases, such as proteinuria, chronic kidney diseases, and kidney failure. Currently, nephropathy that develops into kidney failure is increasing globally, as indicated by the increasing number of patients undergoing hemodialysis. Some developed analytical methods for nephropathy using albumin, creatinine, uric acid, and the urinary albumin-to-creatine ratio biomarkers, including spectrophotometry, turbidimetric immunoassay, and ELISA, have been reported so far, providing good accuracy and precision. However, WHO has established guidelines for developing diagnostic tools that meet several criteria: Affordable, Sensitive, Specific, User-friendly, Rapid and Robust, Equipment-free, Delivered to those who need it. This means that nephropathy detection can be carried out using a simple method compatible with point-of-care that allows independent urine analysis by patients. For this purpose, the use of paper-based analytical devices (PADs) as an alternative platform for the detection of albumin, creatinine, uric acid, and the urinary albumin-to-creatine ratio were reviewed.

Indexed as

Point-of-Care SystemsRenal Insufficiency, ChronicBiomarkersCreatinineHumansProteinuriaBiomarkersCreatinineDiagnostic toolsKidney diseaseNephropathyPaper-based devicesPoint of care

Identifiers

PMID35287205
OpenAlexW3210753654

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.